• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗一家大型教学医院收治的新冠肺炎患者病情严重程度与实验室检查结果及中性粒细胞与淋巴细胞比值的关系:一项横断面研究。

The relationship of COVID-19 severity with laboratory findings and neutrophil-to-lymphocyte ratio in patients admitted to a large teaching hospital in Iran: A cross-sectional study.

作者信息

Khazaeipour Zahra, Gholamzadeh Marsa, Behnoush Amir Hossein, Pestei Khalil

机构信息

Brain and Spinal Cord Injury Research Center, Neuroscience Institute Tehran University of Medical Sciences Tehran Iran.

Health Information Management and Medical Informatics Department, School of Allied Medical Sciences Tehran University of Medical Sciences Tehran Iran.

出版信息

Health Sci Rep. 2024 Sep 5;7(9):e70045. doi: 10.1002/hsr2.70045. eCollection 2024 Sep.

DOI:10.1002/hsr2.70045
PMID:39246725
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11377493/
Abstract

BACKGROUND AND AIMS

COVID-19 patients might be admitted to the hospital based on their clinical manifestations or to the intensive care unit (ICU) due to the severity of their symptoms or critical situation. Our main objective was to investigate clinical and demographic factors influencing COVID-19 patients' admission to the ICU and length of stay (LOS) using extracted data from the hospital information systems in Iran.

METHODS

The data of hospitalized patients with confirmed COVID-19 were retrieved from the health information system of Imam Khomeini Hospital Complex, Tehran, Iran between March 2020 and February 2022. The primary outcome was the ICU admission, and the secondary outcome was the LOS. The correlation analysis between laboratory findings and demographic data with ICU admission and LOS was done using SPSS 21.0, and  < 0.05 was considered significant.

RESULTS

Of all the 4156 patients, 2391 (57.5%) were male and the mean age was 58.69 ± 8.19 years. Of these, 9.5% of patients were admitted to ICU at any time point during their hospital stay. Age and laboratory variables such as neutrophil-to-lymphocyte ratio (NLR), ALT (U/L), albumin (g/dL), plasma glucose (mg/dL), ferritin levels (ng/mL), and phosphorous levels (mg/dL) shown the significant relationship with ICU admission. Also, being a smoker and having hypoxemia had a significant relationship with longer stays in the hospital. In this study, we validated a cut-off value of 4.819 for NLR, calculated at hospitalization, as a useful predictor of disease progression and occurrence of serious clinical outcomes, such as ICU admission.

CONCLUSION

The study examined various clinical factors associated with ICU admission in COVID-19 patients. The findings suggest that certain factors can increase the risk of ICU admission and influence the length of hospital stay which should be focused in future studies.

摘要

背景与目的

COVID-19患者可能因其临床表现而入院,或因症状严重或病情危急而入住重症监护病房(ICU)。我们的主要目标是利用从伊朗医院信息系统提取的数据,调查影响COVID-19患者入住ICU及住院时间(LOS)的临床和人口统计学因素。

方法

2020年3月至2022年2月期间,从伊朗德黑兰伊玛目霍梅尼医院综合健康信息系统中检索确诊COVID-19的住院患者数据。主要结局是入住ICU,次要结局是住院时间。使用SPSS 21.0对实验室检查结果和人口统计学数据与入住ICU及住院时间进行相关性分析,P < 0.05被认为具有统计学意义。

结果

在所有4156例患者中,2391例(57.5%)为男性,平均年龄为58.69 ± 8.19岁。其中,9.5%的患者在住院期间的任何时间点入住ICU。年龄以及中性粒细胞与淋巴细胞比值(NLR)、谷丙转氨酶(U/L)、白蛋白(g/dL)、血糖(mg/dL)、铁蛋白水平(ng/mL)和磷水平(mg/dL)等实验室变量与入住ICU显著相关。此外,吸烟和低氧血症与住院时间延长显著相关。在本研究中,我们验证了住院时计算的NLR临界值4.819作为疾病进展和严重临床结局(如入住ICU)发生的有用预测指标。

结论

本研究探讨了与COVID-19患者入住ICU相关的各种临床因素。研究结果表明,某些因素可增加入住ICU的风险并影响住院时间,这应是未来研究的重点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa1/11377493/7a95749ed31a/HSR2-7-e70045-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa1/11377493/7a95749ed31a/HSR2-7-e70045-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa1/11377493/7a95749ed31a/HSR2-7-e70045-g001.jpg

相似文献

1
The relationship of COVID-19 severity with laboratory findings and neutrophil-to-lymphocyte ratio in patients admitted to a large teaching hospital in Iran: A cross-sectional study.伊朗一家大型教学医院收治的新冠肺炎患者病情严重程度与实验室检查结果及中性粒细胞与淋巴细胞比值的关系:一项横断面研究。
Health Sci Rep. 2024 Sep 5;7(9):e70045. doi: 10.1002/hsr2.70045. eCollection 2024 Sep.
2
Neutrophil-to-lymphocyte ratio as a predictor of clinical outcomes in critically ill COVID-19 patients: A retrospective observational study.中性粒细胞与淋巴细胞比值作为危重症COVID-19患者临床结局的预测指标:一项回顾性观察研究。
Health Sci Rep. 2022 Sep 15;5(5):e844. doi: 10.1002/hsr2.844. eCollection 2022 Sep.
3
Predictors of Intensive Care Unit Admission among Hospitalized COVID-19 Patients in a Large University Hospital in Tehran, Iran.伊朗德黑兰一家大型大学医院中住院的新冠肺炎患者重症监护病房收治的预测因素
J Res Health Sci. 2021 Feb 21;21(1):e00510. doi: 10.34172/jrhs.2021.44.
4
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
5
Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.中性粒细胞与淋巴细胞比值和其他炎症标志物可预测住院 COVID-19 患者的不良结局。
Egypt J Immunol. 2022 Apr;29(2):57-67.
6
Demographic Characteristics, Comorbidities, and Length of Stay of COVID-19 Patients Admitted Into Intensive Care Units in Saudi Arabia: A Nationwide Retrospective Study.沙特阿拉伯重症监护病房收治的COVID-19患者的人口统计学特征、合并症及住院时间:一项全国性回顾性研究
Front Med (Lausanne). 2022 Jul 13;9:893954. doi: 10.3389/fmed.2022.893954. eCollection 2022.
7
Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system.在一个多机构医疗系统中,2019冠状病毒病检测呈阳性的住院患者发生深静脉血栓形成和肺栓塞预示着更高的死亡率以及更长的重症监护病房住院时间和医院住院时间。
J Vasc Surg Venous Lymphat Disord. 2021 Nov;9(6):1361-1370.e1. doi: 10.1016/j.jvsv.2021.03.009. Epub 2021 Apr 6.
8
High risk of malnutrition among hospitalised coronavirus disease 2019 (COVID-19) patients is associated with mortality and other clinical outcomes.2019年冠状病毒病(COVID-19)住院患者中营养不良的高风险与死亡率及其他临床结局相关。
Clin Nutr ESPEN. 2024 Jun;61:1-7. doi: 10.1016/j.clnesp.2024.02.023. Epub 2024 Mar 4.
9
Clinical Characteristics and Outcomes of 905 COVID-19 Patients Admitted to Imam Khomeini Hospital Complex in the Capital City of Tehran, Iran.德黑兰首都伊玛目霍梅尼医院综合大楼 905 例 COVID-19 患者的临床特征和结局。
Arch Iran Med. 2020 Nov 1;23(11):766-775. doi: 10.34172/aim.2020.102.
10
Mortality in ICU COVID-19 Patients Is Associated with Neutrophil-to-Lymphocyte Ratio (NLR): Utility of NLR as a Promising Immunohematological Marker.重症监护病房中感染新型冠状病毒肺炎患者的死亡率与中性粒细胞与淋巴细胞比值(NLR)相关:NLR作为一种有前景的免疫血液学标志物的效用
Interdiscip Perspect Infect Dis. 2023 Nov 9;2023:9048749. doi: 10.1155/2023/9048749. eCollection 2023.

本文引用的文献

1
The utility of syndecan-1 circulating levels as a biomarker in patients with previous or active COVID-19: a systematic review and meta-analysis.循环性硫酸乙酰肝素蛋白聚糖-1 水平作为既往或活动性 COVID-19 患者生物标志物的效用:系统评价和荟萃分析。
BMC Infect Dis. 2023 Aug 4;23(1):510. doi: 10.1186/s12879-023-08473-9.
2
Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis.白细胞介素-6 水平升高与长新冠有关:系统评价和荟萃分析。
Infect Dis Poverty. 2023 Apr 24;12(1):43. doi: 10.1186/s40249-023-01086-z.
3
Galectins can serve as biomarkers in COVID-19: A comprehensive systematic review and meta-analysis.
半乳糖凝集素可作为 COVID-19 的生物标志物:一项全面的系统评价和荟萃分析。
Front Immunol. 2023 Feb 23;14:1127247. doi: 10.3389/fimmu.2023.1127247. eCollection 2023.
4
Risk Factors for In-Hospital Mortality among Patients with Coronavirus-19 in Isfahan City, Iran.伊朗伊斯法罕市新冠肺炎患者院内死亡的危险因素
Adv Biomed Res. 2022 Dec 26;11:121. doi: 10.4103/abr.abr_86_21. eCollection 2022.
5
Systematic Review of Endocan as a Potential Biomarker of COVID-19.系统评价内脂素作为 COVID-19 潜在生物标志物的研究
Angiology. 2024 Feb;75(2):107-115. doi: 10.1177/00033197231152941. Epub 2023 Jan 21.
6
Characteristics of hospitalized patients with COVID-19 during the first to fifth waves of infection: a report from the Japan COVID-19 Task Force.第一至第五波感染期间 COVID-19 住院患者的特征:日本 COVID-19 工作组的报告。
BMC Infect Dis. 2022 Dec 12;22(1):935. doi: 10.1186/s12879-022-07927-w.
7
Hospital length of stay for COVID-19 patients: a systematic review and meta-analysis.新冠病毒肺炎患者的住院时长:一项系统评价与荟萃分析
Multidiscip Respir Med. 2022 Aug 9;17(1):856. doi: 10.4081/mrm.2022.856. eCollection 2022 Jan 12.
8
Factors associated with mortality, length of hospital stay and diagnosis of COVID-19: Data from a field hospital.与 COVID-19 死亡率、住院时间和诊断相关的因素:来自野战医院的数据。
J Infect Public Health. 2022 Jul;15(7):800-805. doi: 10.1016/j.jiph.2022.06.010. Epub 2022 Jun 21.
9
Laboratory Biomarkers Associated with Severity and Mortality of COVID-19.与 COVID-19 严重程度和死亡率相关的实验室生物标志物。
Clin Lab. 2022 Feb 1;68(2). doi: 10.7754/Clin.Lab.2021.210411.
10
Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.COVID-19 相关死亡风险因素:42 项研究和 423117 例患者的系统评价和荟萃分析。
BMC Infect Dis. 2021 Aug 21;21(1):855. doi: 10.1186/s12879-021-06536-3.